India, May 8 -- Takeda Pharmaceutical Company Ltd. (TAK) Thursday reported lower net profit in its fiscal 2024, while profit before tax surged from last year with growth in revenues. Further, the company lifted dividend, and said it projects higher profit for fiscal 2025, but weak core operating profit and revenues.
In pre-market activity on the NYSE, Takeda shares were losing around 3 percent to trade at $14.61.
In the full year, net profit attributable to owners of the company fell 25.1 percent to 107.93 billion yen or $720 million from last year's 144.08 billion yen.
Earnings per share were 67.23 yen or $0.45, lower than prior year's 91.16 yen.
Core net profit was 775.6 billion yen or 491 yen per share, compared to 756.8 billion yen ...